Advertisement
Hadley Wood, MD, shares her vision as the new editor-in-chief of Urology
Novel research to evaluate noninvasive treatments in ED and chronic pelvic pain
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Study leverages data from the ROSETTA trial
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings expand upon earlier data, providing new noninvasive options
Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment
More on the procedure and the institutional experience
Management of high-risk RMSK in the pre-and current eras of neoadjuvant therapy
Smaller incision may lead to reduced postoperative pain for some patients
Transperineal ultrasound a viable, non-invasive option for monitoring intra-fractional prostate motion
Advertisement
Advertisement